Show simple item record

dc.contributor.authorChang, W
dc.contributor.authorChamie, G
dc.contributor.authorMwai, D
dc.contributor.authorClark, TD
dc.contributor.authorThirumurthy, H
dc.contributor.authorCharlebois, ED
dc.contributor.authorPetersen, M
dc.contributor.authorKabami, J
dc.contributor.authorSsemmondo, E
dc.contributor.authorKadede, K
dc.contributor.authorKwarisiima, D
dc.contributor.authorSang, N
dc.contributor.authorBukusi, EA
dc.contributor.authorCohen, CR
dc.contributor.authorKamya, M
dc.contributor.authorHavlir, DV
dc.contributor.authorKahn, JG.
dc.date.accessioned2017-05-09T07:44:30Z
dc.date.available2017-05-09T07:44:30Z
dc.date.issued2016
dc.identifier.citationJ Acquir Immune Defic Syndr. 2016 Nov 1;73(3):e39-e45.en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/27741031
dc.identifier.urihttp://hdl.handle.net/11295/100832
dc.description.abstractBACKGROUND: In 2013-2014, we achieved 89% adult HIV testing coverage using a hybrid testing approach in 32 communities in Uganda and Kenya (SEARCH: NCT01864603). To inform scalability, we sought to determine: (1) overall cost and efficiency of this approach; and (2) costs associated with point-of-care (POC) CD4 testing, multidisease services, and community mobilization. METHODS: We applied microcosting methods to estimate costs of population-wide HIV testing in 12 SEARCH trial communities. Main intervention components of the hybrid approach are census, multidisease community health campaigns (CHC), and home-based testing for CHC nonattendees. POC CD4 tests were provided for all HIV-infected participants. Data were extracted from expenditure records, activity registers, staff interviews, and time and motion logs. RESULTS: The mean cost per adult tested for HIV was $20.5 (range: $17.1-$32.1) (2014 US$), including a POC CD4 test at $16 per HIV+ person identified. Cost per adult tested for HIV was $13.8 at CHC vs. $31.7 by home-based testing. The cost per HIV+ adult identified was $231 ($87-$1245), with variability due mainly to HIV prevalence among persons tested (ie, HIV positivity rate). The marginal costs of multidisease testing at CHCs were $1.16/person for hypertension and diabetes, and $0.90 for malaria. Community mobilization constituted 15.3% of total costs. CONCLUSIONS: The hybrid testing approach achieved very high HIV testing coverage, with POC CD4, at costs similar to previously reported mobile, home-based, or venue-based HIV testing approaches in sub-Saharan Africa. By leveraging HIV infrastructure, multidisease services were offered at low marginal costs.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.titleImplementation and operational research: cost and efficiency of a hybrid mobile multidisease testing approach with high HIV testing coverage in East Africa.en_US
dc.typeArticleen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States